Symptomatic relapse of neurologic syphilis after benzathine penicillin G therapy for primary or secondary syphilis in HIV-infected patients

Clinical Infectious Diseases

Volumn 43, Issue 6, 2006, Pages 787-790

  Walter, T ^a   Lebouche, B ^a   Miailhes, P ^a   Cotte, L ^a   Roure, C ^b   Schlienger, I ^a   Trepo, C ^a  

^a HÔTEL DIEU   (France)

^b CROIX ROUSSE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BENZATHINE PENICILLIN; CEFTRIAXONE;

ADULT; ARTICLE; CASE REPORT; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID EXAMINATION; FLUORESCENT TREPONEMA ANTIBODY TEST; HEMAGGLUTINATION TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NEUROSYPHILIS; PRIORITY JOURNAL; SEROLOGY; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; TREATMENT OUTCOME; TREPONEMA PALLIDUM; VENEREAL DISEASE REACTION TEST;

ADULT; ANTI-BACTERIAL AGENTS; CEFTRIAXONE; COHORT STUDIES; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; NEUROSYPHILIS; PENICILLIN G, BENZATHINE; RECURRENCE; SYPHILIS;

EID: 33748331163     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/507099     Document Type: Article

References (16)

1. Centers for Disease Control and Prevention. Primary and secondary syphilis - United States, 2000-2001. MMWR Morb Mortal Wkly Rep 2002; 51:971-3.
2. Ashton M, Sopwith W, Clark P, McKelvey D, Lighton L, Mandal D. An outbreak no longer: factors contributing to the return of syphilis in Greater Manchester. Sex Transm Infect 2003; 79:291-3.
3. Marra CM, Maxwell CL, Smith SL, et al. Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis 2004; 189:369-76.
4. Lynn WA, Lightman S. Syphilis and HIV: a dangerous combination. Lancet Infect Dis 2004; 4:456-66.
5. Hopkins S, Khalid A, Courtney G, Mulcahy F, Bergin C. Syphilis treatment outcomes in HIV-infected and non-infected individuals [abstract 771]. In: Program and abstracts of the 11th Annual Meeting of the Conference on Retroviruses and Opportunistic Infections (San Francisco). Alexandria, VA: Foundation for Retrovirology and Human Health, 2004:353.
6. Gordon SM, Eaton ME, George R, et al. The response of symptomatic neurosyphilis to high-dose intravenous penicillin G in patients with human immunodeficiency virus infection. N Engl J Med 1994;331:1469-73.
7. Singh AE, Romanowski B. Syphilis: review with emphasis on clinical, epidemiologic, and some biologic features. Clin Microbiol Rev 1999; 12:187-209.
8. Flores JL. Syphilis: a tale of twisted treponemes. West J Med 1995; 163:552-9.
9. Malone JL, Wallace MR, Hendrick BB, et al. Syphilis and neurosyphilis in a human immunodeficiency virus type-1 seropositive population: evidence for frequent serologic relapse after therapy. Am J Med 1995; 99:55-63.
10. Berry CD, Hooton TM, Collier AC, Lukehart SA. Neurologic relapse after benzathine penicillin therapy for secondary syphilis in a patient with HIV infection. N Engl J Med 1987; 316:1587-9.
11. Myint M, Bashiri H, Harrington RD, Marra CM. Relapse of secondary syphilis after benzathine penicillin G: molecular analysis. Sex Transm Dis 2004; 31:196-9.
12. Marra CM, Gary DW, Kuypers J, Jacobson MA. Diagnosis of neurosyphilis in patients infected with human immunodeficiency virus type 1. J Infect Dis 1996; 174:219-21.
13. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. MMWR Recomm Rep 2002; 51:1-78.
14. Pao D, Goh BT, Bingham JS. Management issues in syphilis. Drugs 2002; 62:1447-61.
15. Marra CM, Boutin P, McArthur JC, et al. A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virus-infected individuals. Clin Infect Dis 2000; 30:540-4.
16. Dowell ME, Ross PG, Musher DM, Cate TR, Baughn RE. Response of latent syphilis or neurosyphilis to ceftriaxone therapy in persons infected with human immunodeficiency virus. Am J Med 1992; 93:481-8.